Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Hughes

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|September 5, 2009
Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptabilityBarbara Stanley, Gregory Brown, David A Brent, et al.
The Journal of Nutrition|June 15, 2012
Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during Lyme infectionDarren S Dumlao, Anna M Cunningham, Laura E Wax, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2023
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosisAli Mohamed Ali, Belén P Solans, Anneke C Hesseling, et al.
The European Respiratory Journal|October 27, 2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimenNorbert Ndjeka, Kathryn Schnippel, Iqbal Master, et al.
The European Respiratory Journal|May 5, 2018
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South AfricaErika Mohr, Jennifer Hughes, Anja Reuter, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2016
Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistSusana Frago, Ryan D Nicholls, Madeleine Strickland, et al.
The Lancet. Respiratory Medicine|September 8, 2018
Time to act on injectable-free regimens for children with multidrug-resistant tuberculosisJames A Seddon, H Simon Schaaf, Ben J Marais, et al.
Journal of Geriatric Physical Therapy (2001)|July 20, 2012
Development and validation of a falls-grading scaleMarcela Davalos-Bichara, Frank R Lin, John P Carey, et al.
Journal of Psychiatric Research|January 10, 2020
Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD)Madhukar H Trivedi, Cherise R Chin Fatt, Manish K Jha, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Child and Adolescent Psychiatry|September 5, 2009
Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptabilityBarbara Stanley, Gregory Brown, David A Brent, et al.
The Journal of Nutrition|June 15, 2012
Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during Lyme infectionDarren S Dumlao, Anna M Cunningham, Laura E Wax, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2023
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosisAli Mohamed Ali, Belén P Solans, Anneke C Hesseling, et al.
The European Respiratory Journal|October 27, 2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimenNorbert Ndjeka, Kathryn Schnippel, Iqbal Master, et al.
The European Respiratory Journal|May 5, 2018
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South AfricaErika Mohr, Jennifer Hughes, Anja Reuter, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2016
Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistSusana Frago, Ryan D Nicholls, Madeleine Strickland, et al.
The Lancet. Respiratory Medicine|September 8, 2018
Time to act on injectable-free regimens for children with multidrug-resistant tuberculosisJames A Seddon, H Simon Schaaf, Ben J Marais, et al.
Journal of Geriatric Physical Therapy (2001)|July 20, 2012
Development and validation of a falls-grading scaleMarcela Davalos-Bichara, Frank R Lin, John P Carey, et al.
Journal of Psychiatric Research|January 10, 2020
Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD)Madhukar H Trivedi, Cherise R Chin Fatt, Manish K Jha, et al.
Pageof 10